{'fraction_non_alphanumeric': 0.04318618042226487, 'fraction_numerical': 0.019673704414587333, 'mean_word_length': 5.376146788990826, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
A cell-based model of α-synucleinopathy for screening compounds with therapeutic potential of Parkinson's disease

AbstractAim:To develop a cell-based model by stable transfection of SH-SY5Y with mutant A53T human α-synuclein, recapitulating neurotoxicity of α-synuclein overexpression.Methods:The overexpression of mutant α-synuclein was analyzed by Western blotting, immunocytochemistry, and RT-PCR. Cell viability was processed when treated with different concentrations of 1-methyl-4-phenyl-pyridinium (MPP+) and exogenous dopamine (DA) for 24, 48, and 72 h by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Early apoptosis and late apoptosis/necrosis were analyzed by flow cytometry using Annexin V and propidium iodide double staining, respectively. DNA was isolated and applied to agarose gel for electrophoresis; the typical DNA “ladder” represented severe apoptosis. We also used this model to screen 99 compounds with therapeutic potential by MTT assay.Results:One of the stably-transfected clones overexpressed exogenous genes on both the protein level and the transcriptive level. Significant differences in cytotoxicity were found between the pcDNA3.1(+) group and the pcDNA3. 1(+)-hmα-synuclein group in the presence of the same concentration of MPP+ and DA within the same incubation time. The level of either early apoptosis or late apoptosis/necrosis was remarkably increased in transfected cells compared with the control after treatment with 100 μmol/L MPP+ for 24 h. In addition, the presence of the typical DNA “ladder” was observed in the pcDNA3.1(+)-hmα-synuclein group when treated with 200 μmol/L MPP+ for 48 h. After the screening experiment, 12 of the 99 compounds were found to decrease DA-induced cytotoxicity on cell viability.Conclusion:We established a cell-based model which is useful for studying the function of α-synuclein and screening compounds with therapeutic potential. In addition, it was identified that cells overexpressing A53T mutant α-synuclein were significantly vulnerable against MPP+ or dopamine exposures.